XORTX Therapeutics Inc. (XRTX)
NASDAQ: XRTX · Real-Time Price · USD
0.8934
-0.0052 (-0.58%)
At close: Oct 8, 2025, 4:00 PM EDT
0.9199
+0.0265 (2.97%)
After-hours: Oct 8, 2025, 7:45 PM EDT
XORTX Therapeutics Market Cap
XORTX Therapeutics has a market cap or net worth of $4.44 million as of October 8, 2025. Its market cap has increased by 3.53% in one year.
Market Cap
4.44M
Enterprise Value
3.48M
1-Year Change
3.53%
Ranking
Category
Stock Price
$0.89
Market Cap Chart
Since January 11, 2018, XORTX Therapeutics's market cap has decreased from $25.10M to $4.44M, a decrease of -82.29%. That is a compound annual growth rate of -20.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 4.60M | 12.47% |
| Dec 30, 2024 | 4.09M | -6.85% |
| Dec 29, 2023 | 4.39M | -63.14% |
| Dec 30, 2022 | 11.91M | -53.60% |
| Dec 31, 2021 | 25.66M | 177.78% |
| Dec 31, 2020 | 9.24M | 19.02% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 11, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 758.63B |
| Johnson & Johnson | 453.15B |
| AbbVie | 406.64B |
| UnitedHealth Group | 324.93B |
| Novo Nordisk | 269.41B |
| AstraZeneca | 265.89B |
| Novartis AG | 257.47B |
| Abbott Laboratories | 232.77B |